Evidence map›Paper›PMID 32514069›Full record

ArticleScientific reports2020

Author Correction: Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-Sulfotransferase.

David F Thieker, Yongmei Xu, Digantkumar Chapla, Chelsea Nora, Hong Qiu, Thomas Felix, Lianchun Wang, Kelley W Moremen, Jian Liu, Jeffrey D Esko and 1 more

Open access · goldAbstract readPublished Erratum
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

David F ThiekerDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, GA, 30602, USA.ORCID http://orcid.org/0000-0003-0786-8278
Yongmei XuDivision of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Rm 1044, Genetic Medicine Building, Chapel Hill, USA.
Digantkumar ChaplaComplex Carbohydrate Research Center, University of Georgia, Athens, GA, 30602, USA.
Chelsea NoraDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California, USA.
Hong QiuComplex Carbohydrate Research Center, University of Georgia, Athens, GA, 30602, USA.
Thomas FelixDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, GA, 30602, USA.
Lianchun WangDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, GA, 30602, USA.ORCID http://orcid.org/0000-0003-1454-2719
Kelley W MoremenDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, GA, 30602, USA.ORCID http://orcid.org/0000-0003-1768-582X
Jian LiuDivision of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Rm 1044, Genetic Medicine Building, Chapel Hill, USA.
Jeffrey D EskoDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California, USA.ORCID http://orcid.org/0000-0001-8322-1834
Robert J WoodsDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, GA, 30602, USA. rwoods@ccrc.uga.edu.
University of Georgia · USUniversity of California San Diego · USUniversity of North Carolina at Chapel Hill · US

Funding

Synthesis and Pharmacological Evaluation of Homogenous Ultra-Low Molecular Weight HeparinsR01HL144970 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LIU, JIAN · 2019 to 2021
$946k
NHLBI NIH HHS R01 HL144970
6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID32514069
PMCPMC7280261
OpenAlexW3033931907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.